Xometry, Inc. current report, 10 February 2022

Xometry, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Xometry, Inc. on February 11, 2022, covering events occurring on February 10, 2022. The filing details the exercise of an option by initial purchasers to acquire additional debt securities.

Key Financial Metrics

  • Debt Issuance: The Company issued an additional $37.5 million aggregate principal amount of 1.00% Convertible Senior Notes due 2027.
  • Total Offering Size: This issuance follows an initial offering of $250 million, bringing the total aggregate principal amount of the Notes to $287.5 million.
  • Interest Rate: 1.00% per annum.
  • Maturity Date: 2027.
  • Conversion Terms: The Additional Notes are convertible into shares of Class A Common Stock at an initial conversion rate of 22.7221 shares per $1,000 principal amount.
  • Potential Dilution: Up to 852,078 shares of Common Stock may be issued upon conversion of the Additional Notes.

Note: This filing does not provide data on revenue, profit, cash flow, margins, or liquidity positions.

Material Changes

The primary material change is the increase in the Company's direct financial obligations due to the full exercise of the 13-day option by initial purchasers. The Additional Notes share identical terms with the Initial Notes issued on February 4, 2022.

Outlook, Risks, and Unusual Items

  • Unregistered Sale: The Additional Notes were sold in reliance on exemptions from registration under Section 4(a)(2) of the Securities Act and Rule 144A.
  • Resale Restrictions: The Notes and shares issuable upon conversion are not registered and may not be offered or sold in the United States absent registration or an applicable exemption.
  • Conversion Exemption: Shares issued upon conversion are anticipated to be exempt from registration under Section 3(a)(9) of the Securities Act.

Investor Verification Checklist

  • Verify the total outstanding principal of the 1.00% Convertible Senior Notes due 2027 ($287.5 million).
  • Review the Indenture and Note form (Exhibits 4.1 and 4.2 of the February 4, 2022, 8-K) for specific covenants and conversion mechanics.
  • Assess the potential dilution impact of 852,078 additional shares if the Notes are converted.
  • Confirm the Company's use of proceeds from the total $287.5 million offering as disclosed in the Prior 8-K.